Sickle cell disease (SCD) ranks high among genetic disorders worldwide. It is characterised by repeated vaso-occlusion with resultant end-organ damage. This process can occur in all vascular beds in the body, including ocular blood vessels and may cause irreversible blindness in advanced stages. Little is known of the relationship between the prevalence of ocular abnormalities among children with SCD and their disease severity.
Methods:
A descriptive cross-sectional study was carried out at the Paediatric Haematology Clinics and the Eye Centre of the Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife. Children with SCD in steady state were recruited from the Haematology Clinics and examined for ocular abnormalities at the Eye Centre of the hospital. The subjects SCD severity grade was determined using a previously validated scoring system.
Results:
One hundred and twenty (120) children aged 5 to 15 years were examined. Of these, 72 had one or more ocular abnormalities giving the prevalence of ocular abnormalities among them to be 60.0%. Though a higher proportion of children with moderate disease, 23 (65.7%) of 35, compared to those with mild disease, 49 (57.6%) of 85 had ocular abnormalities, this difference was not statistically significant, p = 0.412.
Conclusion:
Ocular abnormalities among Nigerian children with SCD are common even in steady-state, but not significantly associated with disease severity. Periodic screening for ocular abnormalities should thus be done on them irrespective of disease severity.
FlemingAFStoreyJMolineauxL, et al. Abnormal haemoglobins in Sudan savannah of Nigeria: prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol1979; 73(2): 161–172.
4.
NwogohBNAdewoyinASIheanachoOE, et al. Prevalence of haemoglobin variants in Benin city, Nigeria. Ann Biomed Sci2012; 11: 60–64.
5.
AdekileADAdeoduOO. Haemoglobinopathies. In: AzubikeJCNkanginiemeEO (eds) Paediatrics and child health in a tropical region. 2nd ed.Port Harcourt: University of Port Harcourt press, 2007, pp. 373–390.
6.
BabalolaOEWambebeCO. Ocular morbidity of sickle cell disease in a Nigerian cohort. Niger Postgrad Med J2005; 12(4): 241–244.
7.
PompaSE. Ocular manifestation of sickle haemoglobinopathies. Clin Eye Vis Care1996; 8: 111–117.
8.
Osaafo-KwakoAKimaniKIlakoD, et al. Ocular manifestations of sickle cell disease at Korle-bu Hospital, Accra, Ghana. Eur J Ophthalmol2011; 21: 484–489.
9.
Ntim-AmponashCTEwusiRKIdirisuriya-KhairR, et al. Evaluation of risk factors for advanced glaucoma in Ghanaian patients. Eye2005; 19(5): 528–534.
10.
CohenFBFletcherMEGoldbergMF, et al. Diagnosis and management of ocular complications of sickle haemoglobinopathies. Ophthalmic Surg1986; 17(6): 369–374.
11.
ScottAW. Ophthalmic manifestations of sickle cell disease. South Med J2016; 109: 542–548.
12.
EruchaluUVPamVAAkuseRM. Ocular findings in children with severe clinical symptoms of homozygous sickle cell anaemia in Kaduna, Nigeria. West Afr J Med2006; 25(2): 88–91.
13.
LagunjuIABrownBJ. Adverse neurological outcomes in Nigerian children with sickle cell disease. Int J Hematol2012; 96(6): 710–718.
14.
KaimboWAKaimboDNgiyuluR. Ocular findings in children with homozygous sickle cell disease in Democratic Republic of Congo. Bull Soc Belge Ophtalmol2000; 275: 27–30.
15.
GeorgeIOCookeySAH. Eye manifestations of children with homozygous sickle cell disease in Nigeria. J Med Med Sci2012; 3(5): 302–305.
16.
OluleyeTSBrownBJOlawoyeO. Ocular manifestations of children with sickle cell disease in Ibadan, Nigeria. East Afr Med J2017; 94(10): 812–819.
17.
BallasSKLieffSBenjaminLJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol2010; 85(1): 6–13.
18.
OyedejiGA. Socioeconomic and cultural background of hospitalized children in Ilesa. Nig J Paediatr1985; 12: 111–117.
19.
AdegokeSAKutiBP. Evaluation of clinical severity of sickle cell anaemia in Nigerian Children. J Appl Hematol2013;4: 58–64.
20.
Diseases of the Eye and Adnexa. International statistical classification of diseases and related health problems. 10th Revision, https://icd.who.int/browse10/2010/en (2010accessed 15 September 2019).
21.
KanskiJJBowlingB. Clinical ophthalmology. A systemic approach. China: Elsevier, 2011.
22.
SerjeantGRSerjeantBECondonPI. The conjuctival sign in sickle cell anaemia. A relationship between irreversibly sickled cells. JAMA1972; 219: 1428–1431.
23.
AlbertDMDryjaTP. Cataract. In: RamziSVinayKTuckerC (eds) Pathologic basis of diseases. 6th ed. Philadelphia, PA: Elsevier1999, pp. 1367–1368.
24.
ChangRTSinghK. Glaucoma suspect: diagnosis and management. Asia Pac J Ophthalmol2016; 5: 32–37.
25.
AyanniyiAAOlatunjiFOMahmoudAO, et al. Clinical findings among Nigerian paediatric glaucoma suspects during a school eye health survey. Open Ophthalmol J2008; 2: 137–140.
VarmaDDCugatiSLeeAW, et al. A review of central retinal artery occlusion: clinical presentation and management. Eye2013; 27: 688–697.
29.
BwalyaWM. Ocular manifestation of sickle cell disease. Masters in Medicine (Ophthalmology), University Teaching Hospital, Lusaka, Zambia, 2014.
30.
GoldbergM. Sickle cell retinopathy. In: DuaneTJeagerE (eds) Clinical opthalmology. Philaldelphia, PA: Harper and Row Publishers, 1982, pp. 1–45.
31.
LoggettoSR. Sickle cell anaemia: clinical diversity and beta S-globin haplotypes. Rev Bras Hemoter2013; 35: 155–157.
32.
PowarsDHitiA. Sickle cell anaemia. Beta S gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child1993; 147: 1197–1202.
33.
AkinsolaFBKehindeMO. Ocular findings in sickle cell disease patients in Lagos. Niger Postgrad Med J2004; 11: 203–206.
34.
Van MeursJC. Vision-threatening eye manifestations in patients with sickle cell disease on curacao. Ned Tijdschr Geneeskd1990; 134: 1800–1802.
35.
LaiJCFekratSBarronY, et al. Traumatic hypheama in children: risk factor for complications. Arch Ophthalmol2001; 119: 64–70.
36.
SommerAPollackIMaumeneeAE. Optic disc parameters and onset of glaucomatous field loss. Methods and progressive change in disc morphology. Arch Ophthalmol1979; 97(8): 1449–1454.
37.
EdmundsBPapadopoulousMLohAFenertyC. Secondary glaucoma: glaucoma associated with acquired conditions. American Academy of Ophthalmology, 2015. http://www.aao.org (accessed 24 June 2016).
El-GhamrawyMKHannFBehairyE, et al. Ocular manifestations in children and young adults with sickle cell disease. Indian J Hematol Blood Transfus2014; 30: 275–280.
41.
FoxPDDunnDTJoanneSM, et al. Risk factors for proliferative sickle retinopathy. Br J Ophthalmol1990; 74: 172–176.
42.
TantawyAGAndrawesNGAdlyAM, et al. Retinal changes in children and adolescent with sickle cell disease attending a paediatric hospital in Egypt: risk factors and relation to ophthalmic and cerebral blood flow. Tras R Soc Trop Med Hyg2013; 107: 205–211.
43.
BunnH. Pathogenesis and treatment of sickle cell disease. N Engl J Med1997; 337: 762–769.
